Promise Proteomics
Promise Proteomics is a French biotech that develops CE-IVDR certified LC-MS quantification kits (mAbXmise) and stable isotope labelled protein standards for clinical labs and bioanalytical scientists performing therapeutic monoclonal antibody monitoring and protein quantification.
- Company typePrivate
- Founded2010
- HeadquartersGrenoble, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Promise Proteomics does
Promise Proteomics (PROMISE PROTEOMICS S.A.S.) is a Grenoble-based French biotechnology company founded in 2010 that develops mass spectrometry-based reagents and IVD kits for the absolute quantification of proteins and monoclonal antibodies in biological samples. The company's core technology uses Stable Isotope Labelled (SIL) proteins and monoclonal antibodies as internal standards for LC-MS/MS quantification, including a proprietary CutXmise protease used in sample preparation. Its flagship commercial line is the mAbXmise platform — CE-IVDR certified by BSI (Notified Body 2797) — comprising ready-to-use IVD kits (ITDM2, IADA1, PNHTDM, HTDM) for therapeutic drug monitoring of monoclonal antibodies and anti-drug antibody detection across inflammation, oncology, nephrology, hematology, hemophilia, and transplantation indications.
The company operates three commercial pillars: (1) the mAbXmise IVD kit line sold to clinical laboratories and healthcare professionals across Europe, with availability elsewhere gated by local regulatory registration; (2) a research-use catalog of 52 SIL-Proteins and 45 SIL-mAbs sold to bioanalytical scientists for LC-MS quantification workflows; and (3) custom SIL protein production services. Supporting products include DIGESTIF quality control kits for tryptic digestion and LC-MS performance validation, and eZYDIAG kits for ricin and anthrax detection. Distribution is mixed: direct sales to laboratories in Europe and a global distributor network where regulatory clearance permits. Pricing is structured as non-refundable one-time kit purchases plus project-based custom production fees; no pricing is publicly disclosed.
The commercial strategy is sales-led, with marketing concentrated on the corporate website, the dedicated mAbXmise site, email/newsletter outreach, and collaborative webinars with instrument partners — most notably Waters Corporation, with whom Promise co-validates the Xevo TQ Absolute XR Mass Spectrometer + mAbXmise kit workflow. The company holds 11-50 employees, operates as a privately held SAS, and discloses no funding rounds, M&A activity, or institutional ownership; revenue is not publicly disclosed. Headcount scale, niche specialty diagnostics focus, and Europe-only IVD clearance all imply a small commercial footprint relative to large diagnostics players, with growth dependent on catalog expansion, additional CE-IVDR kit references, and future regulatory clearance outside Europe.
Promise Proteomics firmographics
Firmographics- Name
- Promise Proteomics
- Legal name
- PROMISE PROTEOMICS S.A.S.
- Website
- https://promise-proteomics.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Promise Proteomics is a French biotech that develops CE-IVDR certified LC-MS quantification kits (mAbXmise) and stable isotope labelled protein standards for clinical labs and bioanalytical scientists performing therapeutic monoclonal antibody monitoring and protein quantification.
- Ownership category
- akta.pro rank
Promise Proteomics industry classification
Industry- Product category
- In Vitro Diagnostics & Mass Spectrometry Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
- akta.pro secondary industries
- Proteomics & Biomarker Analytical Testing (HLAGADAG), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Promise Proteomics is headquartered
LocationHeadquarters
- HQ city
- Grenoble
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Promise Proteomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Kit Sales (mAbXmise): Sale of CE-IVD certified mAbXmise quantification kits for therapeutic monoclonal antibody monitoring in patient samples. The kits are non-refundable and intended for laboratory professional use.
- SIL-Proteins and SIL-mAbs Catalog Products: Sale of Stable Isotope Labelled proteins and monoclonal antibodies for bioanalytical research applications, including 52 SIL-Proteins and 45 SIL-mAbs.
- Quality Control Products: Sale of DIGESTIF catalog products for quality control of tryptic digestion and LC-MS performances in clinical research settings.
- Custom Production Services: Custom production of SIL proteins for specific research and diagnostic requirements.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Promise Proteomics product offering
Product offeringCore offering
Promise Proteomics develops and sells CE-IVDR certified in vitro diagnostic kits (mAbXmise) for absolute LC-MS quantification of therapeutic monoclonal antibodies and anti-drug antibodies in patient samples. The company also provides a catalog of Stable Isotope Labelled (SIL) proteins and monoclonal antibodies for bioanalytical research, DIGESTIF quality control kits, custom SIL protein production services, and eZYDIAG diagnostic kits for ricin and anthrax detection.
Product overview
Promise Proteomics is a provider of mass spectrometry-based quantification solutions dedicated to proteins and monoclonal antibodies. The core product offering is the mAbXmise platform, comprising CE-IVDR certified quantification kits (ITDM2, IADA1, PNHTDM, HTDM) for monitoring therapeutic monoclonal antibody drug levels and anti-drug antibodies, along with Research Use Only (RUO) variants. Supporting products include a catalog of 52 Stable-Isotope-Labelled (SIL) proteins and 45 SIL-mAbs used as internal standards, DIGESTIF quality control kits for LC-MS performance validation, and custom SIL protein production services. Additional offerings include eZYDIAG kits for ricin and anthrax detection. The company also provides oncology-focused kits (OTDM, ADC), nephrology/hematology kits (PNHTDM, ALEMP), and transplantation kits (GTDM).
Differentiator
Problem solved
Functional benefit
Brands
- mAbXmise: Quantitative assay kits for monitoring therapeutic monoclonal antibodies concentration in patient samples using LC-MS technology. Includes ITDM kits for drug level quantification and IADA kits for anti-drug antibody detection.
- SIL-Proteins
- SIL-mAbs
- DIGESTIF
- eZYDIAG
Products and services
- mAbXmise Quantification Kits CE-IVDR certified in vitro diagnostic medical devices for laboratory professionals that perform absolute LC-MS quantification of therapeutic monoclonal antibodies, antibody-drug conjugates, or proteins in patient samples. Includes kits for drug level monitoring (ITDM2, PNHTDM, HTDM, OTDM, ADC, GTDM) and anti-drug antibody detection (IADA1, ALEMP).
- SIL-Proteins and SIL-mAbs Catalog Stable-Isotope-Labelled proteins and monoclonal antibodies used as internal standards for mass spectrometry-based absolute quantification. The 2026 catalog includes 52 SIL-Proteins and 45 SIL-mAbs for bioanalytical research applications.
- DIGESTIF Quality Control Kits Quality control solutions for tryptic digestion and LC-MS performance validation, ensuring robustness of mass spectrometry workflows in clinical and research settings.
- Custom Production of SIL Proteins Custom production services for Stable-Isotope-Labelled proteins to meet specific research and development needs of bioanalytical scientists and pharmaceutical R&D labs.
- eZYDIAG Kit Ricin In vitro diagnostic kit for the detection of ricin, a toxic protein. Intended for laboratory professional use.
- eZYDIAG Kit Anthrax In vitro diagnostic kit for the detection of anthrax (Bacillus anthracis). Intended for laboratory professional use.
Quantifiable outcome
- Calibration linearity r²>0.99 for each peptide
- +4 more outcomes
Companies that use Promise Proteomics
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles2 records
Promise Proteomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Promise Proteomics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Waters CorporationcoreCollaborative partnership for mAbs quantification by mass spectrometry. Waters provides the Xevo TQ Absolute XR Mass Spectrometer which is used in combination with Promise Proteomics mAbXmise kits for clinical research applications. The partnership includes joint webinars and application notes demonstrating the combined workflow for inflammation mAbs testing.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Promise Proteomics competitors and assessment
Company assessmentBroad incumbents
- Agilent Technologies: Mass spectrometry and life-science analytics vendor with protein quantification and biopharma TDM capabilities. Comparable because its Triple Quad platforms compete in the same clinical-research LC-MS workflows that Promise's kits target.
- Waters Corporation: Mass spectrometry leader (Xevo TQ Absolute XR) and Promise's core technology partner. Comparable because its instruments and BioAnalysis workflows underpin clinical-research mAb quantification, and it sells competing consumables and informatics for the same applications.
- Thermo Fisher Scientific: Largest life-science tools provider offering LC-MS protein quantification reagents, SIL peptide standards, and immunoassay TDM kits. Comparable because it overlaps directly in mass-spec proteomics workflows and competes for the same clinical-lab TDM budget.
- Merck KGaA (MilliporeSigma): Major life-science tools supplier offering SIL peptides/proteins, proteases, and clinical bioanalysis reagents. Comparable because its research catalog overlaps with Promise's SIL-Proteins and SIL-mAbs offerings and bioanalytical workflow reagents.
Direct peers
- Bio-Rad Laboratories: Clinical diagnostics and life-science research company offering ELISA-based TDM kits and proteomics reagents. Comparable because it competes for clinical-lab TDM budgets with immunoassays that Promise's LC-MS kits aim to displace.
- SCIEX: Mass spectrometry platform vendor with protein quantification workflows and clinical research applications. Comparable because its Triple Quad systems are used in similar LC-MS/MS protein quantification pipelines, and it offers reagent kits for clinical proteomics.
- Promega Corporation: Proteomics reagent and enzyme supplier offering proteases (including trypsin alternatives) and quantification standards for LC-MS workflows. Comparable because its digestion enzymes and standards overlap with Promise's DIGESTIF QC line and SIL catalog.
- Cambridge Isotope Laboratories: Leading supplier of stable isotope-labeled peptides and proteins used as internal standards for LC-MS quantification. Comparable because its SIL catalog directly overlaps with Promise's SIL-Proteins and SIL-mAbs research-use offerings.
Others
- Charles River Laboratories: CRO offering bioanalytical and LC-MS-based protein quantification services for pharmaceutical sponsors. Comparable because it provides outsourced mAb and biomarker quantification as an alternative to in-lab use of Promise's kits.
- Eurofins Scientific: Global bioanalytical contract testing organization performing protein and mAb quantification services for pharma and clinical clients. Comparable because it is an alternative path for therapeutic mAb quantification that competes for the same biopharma TDM testing budget.
Market position
Strengths5 records
Weaknesses5 records
Key risks7 records
Key highlights7 records
Customer concentration
Promise Proteomics social profiles
Digital presencePromise Proteomics compliance and trust
Trust signalCompliance2 records
Promise Proteomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Promise Proteomics leadership team
Management profileNumber of profiles
Promise Proteomics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Promise Proteomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Promise Proteomics
What does Promise Proteomics do?
Promise Proteomics develops and sells CE-IVDR certified in vitro diagnostic kits (mAbXmise) for absolute LC-MS quantification of therapeutic monoclonal antibodies and anti-drug antibodies in patient samples. The company also provides a catalog of Stable Isotope Labelled (SIL) proteins and monoclonal antibodies for bioanalytical research, DIGESTIF quality control kits, custom SIL protein production services, and eZYDIAG diagnostic kits for ricin and anthrax detection.
Is Promise Proteomics a public or private company?
Promise Proteomics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Promise Proteomics founded?
Promise Proteomics was founded in 2010. It employs 11 to 50 people.
Where is Promise Proteomics based?
Promise Proteomics is headquartered in Grenoble, France, in the Europe region.
How does Promise Proteomics make money?
Four revenue lines are on record. Diagnostic Kit Sales (mAbXmise) is the primary driver. The others are SIL-Proteins and SIL-mAbs Catalog Products, quality Control Products and custom Production Services.
Who are Promise Proteomics's main competitors?
Broad incumbents on record are Agilent Technologies, Waters Corporation, Thermo Fisher Scientific and Merck KGaA (MilliporeSigma). Direct peers are Bio-Rad Laboratories, SCIEX, Promega Corporation and Cambridge Isotope Laboratories. Others are Charles River Laboratories and Eurofins Scientific.
Does Promise Proteomics have an API?
No public API is recorded for Promise Proteomics.
What industry is Promise Proteomics in?
Promise Proteomics's product category is In Vitro Diagnostics & Mass Spectrometry Reagents. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 325413 and its SIC code is 2835.